FCE 20700
FCE 20700 is an orally active PGE2 analogue. FCE 20700 can prevent gastric mucosal damage and in inhibit gastric acid and pepsin secretion. FCE 20700 can be used for the research of gastrointestinal ulcer[1].
Product Specifications
CAS Number
89648-76-0
UNSPSC
12352211
Target
Prostaglandin Receptor
Related Pathways
GPCR/G Protein
Field of Research
Inflammation/Immunology
Smiles
CCCC[C@H](C)[C@H](O)C#C[C@@H]1[C@H](C(CC1)=O)C/C=C\CCCC(OC)=O
Molecular Formula
C22H34O4
Molecular Weight
362.50
References & Citations
[1]Morini G, et al. Protective and antisecretory effects of the new PGE2 analogue, FCE 20700, and of 16,16 dimethyl PGE2 in pylorus-ligated rat. Pharmacol Res Commun. 1988 Nov;20 (11) :949-61.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PR0624 2 x 250μl
Tricolor Broad Range Prestained Protein Ladder, 2 x 250µl
Sign In for Pricing
View Details 
PKSH032322-01 10 µg
Recombinant Human Cystatin C/CST3 Protein (E.coli)
Sign In for Pricing
View Details PKSH032322-02 50 µg
Recombinant Human Cystatin C/CST3 Protein (E.coli)
Sign In for Pricing
View Details